SCHEMBL6667769

SCHEMBL6667769

COCCOCCOCCN(Cc1ccc(Cl)cc1)C(=O)c1c[nH]c2ccc(CN3CCOCC3)cc2c1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.43
HPGD P15428 4/20 0.43
KDM4E B2RXH2 3/20 0.43
GLA P06280 1/20 0.43
GAA P10253 1/20 0.43
HSD17B10 Q99714 2/20 0.41
TSHR P16473 1/20 0.41
KMT2A Q03164 2/20 0.40
MAPT P10636 2/20 0.39
POLA1 P09884 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39
KCNH2 Q12809 3/20 0.39
POLB P06746 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
HDAC1 Q13547 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7848275 1.00 ALDH1A1 (0.43) ALDH1A1HPGDKDM4EGLAGAA
SCHEMBL7847400 0.95 ALDH1A1 (0.44) ALDH1A1HPGDKDM4EGLAGAA
SCHEMBL7846819 0.92 HTR2A (0.43) ALDH1A1HPGDKDM4EGLAGAA
SCHEMBL6670162 0.92 HTR2A (0.43) ALDH1A1HPGDKDM4EGLAGAA
SCHEMBL7846612 0.92 HSD17B10 (0.41) ALDH1A1HPGDKDM4EGLAGAA
SCHEMBL7843009 0.89 ALDH1A1 (0.45) ALDH1A1HPGDKDM4EGLAGAA
SCHEMBL6701498 0.87 ALDH1A1 (0.43) ALDH1A1HPGDKDM4EGLAGAA
SCHEMBL7845988 0.87 ALDH1A1 (0.43) ALDH1A1HPGDKDM4EGLAGAA
SCHEMBL7834426 0.85 HSD17B10 (0.46) ALDH1A1HPGDKDM4EGLAHSD17B10
SCHEMBL7858072 0.85 HSD17B10 (0.46) ALDH1A1HPGDKDM4EGLAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004019932-A1 METHOD OF PREVENTING OR TREATING ATHEROSCLEROSIS OR RESTENOSIS PHARMACIA & UPJOHN COMPANY (US) 2004-03-11 WO claimed
EP-1140850-A1 QUINOLINECARBOXAMIDES AS ANTIVIRAL AGENTS PHARMACIA & UPJOHN COMPANY (US) 2001-10-10 EP claimed
WO-2000040561-A1 QUINOLINECARBOXAMIDES AS ANTIVIRAL AGENTS PHARMACIA & UPJOHN COMPANY (US) 2000-07-13 WO claimed
WO-2004019932-A1 METHOD OF PREVENTING OR TREATING ATHEROSCLEROSIS OR RESTENOSIS PHARMACIA & UPJOHN COMPANY (US) 2004-03-11 WO disclosed
EP-1140850-A1 QUINOLINECARBOXAMIDES AS ANTIVIRAL AGENTS PHARMACIA & UPJOHN COMPANY (US) 2001-10-10 EP disclosed
WO-2000040561-A1 QUINOLINECARBOXAMIDES AS ANTIVIRAL AGENTS PHARMACIA & UPJOHN COMPANY (US) 2000-07-13 WO disclosed